Different mutations of the human c-mpl gene indicate distinct haematopoietic diseases
Open Access
- 25 January 2013
- journal article
- review article
- Published by Springer Nature in Journal of Hematology & Oncology
- Vol. 6 (1) , 11
Abstract
The human c-mpl gene (MPL) plays an important role in the development of megakaryocytes and platelets as well as the self-renewal of haematopoietic stem cells. However, numerous MPL mutations have been identified in haematopoietic diseases. These mutations alter the normal regulatory mechanisms and lead to autonomous activation or signalling deficiencies. In this review, we summarise 59 different MPL mutations and classify these mutations into four different groups according to the associated diseases and mutation rates. Using this classification, we clearly distinguish four diverse types of MPL mutations and obtain a deep understand of their clinical significance. This will prove to be useful for both disease diagnosis and the design of individual therapy regimens based on the type of MPL mutations.Keywords
This publication has 76 references indexed in Scilit:
- JAK2V617F and p53 mutations coexist in erythroleukemia and megakaryoblastic leukemic cell linesExperimental Hematology & Oncology, 2012
- A novel mutation in MPL (Y252H) results in increased thrombopoietin sensitivity in essential thrombocythemiaAmerican Journal of Hematology, 2012
- Development of a highly sensitive method for detection of JAK2V617FJournal of Hematology & Oncology, 2011
- Effects of Clinically Relevant MPL Mutations in the Transmembrane Domain Revealed at the Atomic Level through Computational ModelingPLOS ONE, 2011
- Thrombopoietin receptor activation: transmembrane helix dimerization, rotation, and allosteric modulationThe FASEB Journal, 2011
- Relevance of JAK2V617F positivity to hematological diseases - survey of samples from a clinical genetics laboratoryJournal of Hematology & Oncology, 2011
- Characterization of 35 new cases with four different MPLW515 mutations and essential thrombocytosis or primary myelofibrosisHaematologica, 2009
- Evidence for MPL W515L/K mutations in hematopoietic stem cells in primitive myelofibrosisBlood, 2007
- Phenotypic variations and new mutations in JAK2 V617F–negative polycythemia vera, erythrocytosis, and idiopathic myelofibrosisExperimental Hematology, 2007
- MPLW515L Is a Novel Somatic Activating Mutation in Myelofibrosis with Myeloid MetaplasiaPLOS Medicine, 2006